Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C

This study has been terminated.

(Dose levels were determined to be subtherapeutic)

Sponsor:

Information provided by (Responsible Party):

Valeant Pharmaceuticals International, Inc.

ClinicalTrials.gov Identifier:

NCT00305383

First received: March 17, 2006

Last updated: June 21, 2012

Last verified: June 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	May 2007
Estimated Primary Completion Date:	No date given